PREPAIRE SHIELD

Serial Number 97587378
Registration 7517079
700

Registration Progress

Application Filed
Sep 12, 2022
Under Examination
Dec 12, 2023
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered
Sep 24, 2024

Trademark Image

PREPAIRE SHIELD

Basic Information

Serial Number
97587378
Registration Number
7517079
Filing Date
September 12, 2022
Registration Date
September 24, 2024
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 24, 2024
Registration
Registered
Classes
042

Rights Holder

PREPAIRE LABS LIMITED

16
Address
UNIT 11, BLD. 10
CHERRYWOOD BUSINESS PK
LOUGHLINSTOWN D18T3Y1
IE

Ownership History

Prepaire IP Development

Original Applicant
99
George Town KY

Prepaire IP Development

Owner at Publication
99
George Town KY

PREPAIRE LABS LIMITED

New Owner After Publication #1
16
LOUGHLINSTOWN IE

PREPAIRE LABS LIMITED

Original Registrant
16
LOUGHLINSTOWN IE

Legal Representation

Attorney
Natasha N. Reed

USPTO Deadlines

Next Deadline
1876 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-24)
Due Date
September 24, 2030
Grace Period Ends
March 24, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Oct 3, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 3, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Oct 1, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 24, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 24, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 16, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 16, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 1, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 27, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 12, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 12, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Jun 12, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jun 12, 2024 IUAF S USE AMENDMENT FILED Loading...
Jun 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 11, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 12, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 15, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 12, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 12, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Oct 12, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 12, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 12, 2023 EWOR I TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Loading...
Oct 12, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 12, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 14, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 1, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 31, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 31, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 31, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 31, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 31, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 30, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 27, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Drug discovery services; Pharmaceutical research services; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical product evaluation, scientific and technological services and research and design services relating thereto, namely, scientific research, research and design in the fields of pharmaceuticals, agrochemicals, bioactive compounds, fine chemicals, chemical feed stocks, polymers, paints, dyestuffs, adhesives, material sciences, engineering, nanomaterials, and foodstuffs; Chemical research; Chemical research, namely, chemical technological research; Chemical analysis; Chemistry services, namely, chemistry research, laboratory research in the field of chemistry; Chemistry consultation; Scientific research relating to chemistry; Research and development services in the field of chemistry; Design and development of chemical compounds; Design and development of synthetic chemical compounds; Rental of laboratory apparatus and instruments
First Use Anywhere: Oct 18, 2022
First Use in Commerce: Oct 18, 2022

Classification

International Classes
042